Comparison of the pharmacokinetics of erlotinib administered in complete fasting and 2 h after a meal in patients with lung cancer-Reference-Cited by-同舟云学术

Comparison of the pharmacokinetics of erlotinib administered in complete fasting and 2 h after a meal in patients with lung cancer

Published:2015-05-21 Issue:1 Volume:76 Page:125-132
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Katsuya Yuki,Fujiwara Yutaka,Sunami Kuniko,Utsumi Hirofumi,Goto Yasushi,Kanda Shintaro,Horinouchi Hidehito,Nokihara Hiroshi,Yamamoto Noboru,Takashima Yuki,Osawa Satoko,Ohe Yuichiro,Tamura Tomohide,Hamada Akinobu

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-015-2778-8.pdf

Reference17 articles.

1. Mathijssen RH, Sparreboom A, Verweij J (2014) Determining the optimal dose in the development of anticancer agents. Nat Rev Clin Oncol 11(5):272–281

2. Szmulewitz RZ, Ratain MJ (2013) Playing Russian roulette with tyrosine kinase inhibitors. Clin Pharmacol Ther 93(3):242–244

3. Singh BN, Malhotra BK (2004) Effects of food on the clinical pharmacokinetics of anticancer agents: underlying mechanisms and implications for oral chemotherapy. Clin Pharmacokinet 43(15):1127–1156

4. Ratain MJ (2011) Flushing oral oncology drugs down the toilet. J Clin Oncol 29(30):3958–3959

5. Sparreboom, A. and S.D. Baker, Pharmacokinetic studies in early anticancer drug development in Principles of Anticancer Drug Development. 2011: Humana Press/Springer Science

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between Biodistribution and Tracer Kinetics of 11C-Erlotinib, 18F-Afatinib and 11C-Osimertinib and Image Quality Evaluation Using Pharmacokinetic/Pharmacodynamic Analysis in Advanced Stage Non-Small Cell Lung Cancer Patients;Diagnostics;2022-04-01

2. Ketogenic Diet as Adjunctive Therapy for Malignant Brain Cancer;Ketogenic Diet and Metabolic Therapies;2022-04

3. Local Release of TGF‐ β Inhibitor Modulates Tumor‐Associated Neutrophils and Enhances Pancreatic Cancer Response to Combined Irreversible Electroporation and Immunotherapy;Advanced Science;2022-02-07

4. A narrative review of the relationship between TGF-β signaling and gynecological malignant tumor;Annals of Translational Medicine;2021-10

5. Role of TGF-β in pancreatic ductal adenocarcinoma progression and PD-L1 expression;Cellular Oncology;2021-03-10